These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10652981)

  • 21. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risks associated with low-dose combined oral contraceptives].
    Merki-Feld GS
    Ther Umsch; 2001 Sep; 58(9):564-9. PubMed ID: 11594156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing scene--an unnecessary pill crisis.
    Heinemann LA
    Hum Reprod Update; 1999; 5(6):746-55. PubMed ID: 10652983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular safety of oral contraceptives. What has changed in the last decade?
    Ory HW
    Contraception; 1998 Sep; 58(3 Suppl):9S-13S; quiz 65S. PubMed ID: 9807687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    Weill A; Dalichampt M; Raguideau F; Ricordeau P; Blotière PO; Rudant J; Alla F; Zureik M
    BMJ; 2016 May; 353():i2002. PubMed ID: 27164970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and venous thromboembolism: a five-year national case-control study.
    Lidegaard Ø; Edström B; Kreiner S
    Contraception; 2002 Mar; 65(3):187-96. PubMed ID: 11929640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.
    Lewis MA
    Hum Reprod Update; 1999; 5(6):707-20. PubMed ID: 10652980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism.
    Kaper RF; Norpoth T; Rekers H
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):1-15. PubMed ID: 10836658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives and cardiovascular risk.
    Drug Ther Bull; 2000 Jan; 38(1):1-5. PubMed ID: 10820893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
    Horton LG; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The differential risk of oral contraceptives: the impact of full exposure history.
    Lewis MA; MacRae KD; Kühl-Habichl D; Bruppacher R; Heinemann LA; Spitzer WO
    Hum Reprod; 1999 Jun; 14(6):1493-9. PubMed ID: 10359554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives.
    Burnhill MS
    Int J Fertil Womens Med; 1999; 44(1):19-30. PubMed ID: 10206196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.